Literature DB >> 23748077

Mouse models of gene-environment interactions in schizophrenia.

Geetha Kannan1, Akira Sawa, Mikhail V Pletnikov.   

Abstract

Gene-environment interactions (GEIs) likely play significant roles in the pathogenesis of schizophrenia and underlie differences in pathological, behavioral, and clinical presentations of the disease. Findings from epidemiology and psychiatric genetics have assisted in the generation of animal models of GEI relevant to schizophrenia. These models may provide a foundation for elucidating the molecular, cellular, and circuitry mechanisms that mediate GEI in schizophrenia. Here we critically review current mouse models of GEI related to schizophrenia, describe directions for their improvement, and propose endophenotypes to provide a more tangible basis for molecular studies of pathways of GEI and facilitate the identification of novel therapeutic targets. 2013 Elsevier Inc. All rights reserved

Entities:  

Mesh:

Year:  2013        PMID: 23748077      PMCID: PMC3737071          DOI: 10.1016/j.nbd.2013.05.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  103 in total

Review 1.  Toll-like receptor 3: involvement with exogenous and endogenous RNA.

Authors:  Marla Karine Amarante; Maria Angelica Ehara Watanabe
Journal:  Int Rev Immunol       Date:  2010-12       Impact factor: 5.311

2.  Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology.

Authors:  Bagrat Abazyan; Jun Nomura; Geetha Kannan; Koko Ishizuka; Kellie L Tamashiro; Frederick Nucifora; Vladimir Pogorelov; Bruce Ladenheim; Chunxia Yang; Irina N Krasnova; Jean Lud Cadet; Carlos Pardo; Susumu Mori; Atsushi Kamiya; Michael W Vogel; Akira Sawa; Christopher A Ross; Mikhail V Pletnikov
Journal:  Biol Psychiatry       Date:  2010-12-15       Impact factor: 13.382

Review 3.  Catechol-O-methyl transferase as a drug target for schizophrenia.

Authors:  Colm M P O'Tuathaigh; Lieve Desbonnet; Peter Lee; John L Waddington
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-05       Impact factor: 4.388

4.  NURR1 mutations in cases of schizophrenia and manic-depressive disorder.

Authors:  S Buervenich; A Carmine; M Arvidsson; F Xiang; Z Zhang; O Sydow; E G Jönsson; G C Sedvall; S Leonard; R G Ross; R Freedman; K V Chowdari; V L Nimgaonkar; T Perlmann; M Anvret; L Olson
Journal:  Am J Med Genet       Date:  2000-12-04

5.  Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids.

Authors:  Minae Niwa; Hanna Jaaro-Peled; Stephanie Tankou; Saurav Seshadri; Takatoshi Hikida; Yurie Matsumoto; Nicola G Cascella; Shin-ichi Kano; Norio Ozaki; Toshitaka Nabeshima; Akira Sawa
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

Review 6.  Dysconnectivity, large-scale networks and neuronal dynamics in schizophrenia.

Authors:  Peter J Uhlhaas
Journal:  Curr Opin Neurobiol       Date:  2012-12-07       Impact factor: 6.627

Review 7.  GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

8.  Prenatal viral infection of mice at E16 causes changes in gene expression in hippocampi of the offspring.

Authors:  S Hossein Fatemi; Timothy D Folsom; Teri J Reutiman; Hao Huang; Kenichi Oishi; Susumu Mori
Journal:  Eur Neuropsychopharmacol       Date:  2009-06-05       Impact factor: 4.600

9.  Models for the joint effect of genotype and environment on liability to psychiatric illness.

Authors:  K S Kendler; L J Eaves
Journal:  Am J Psychiatry       Date:  1986-03       Impact factor: 18.112

Review 10.  Strategy for investigating interactions between measured genes and measured environments.

Authors:  Terrie E Moffitt; Avshalom Caspi; Michael Rutter
Journal:  Arch Gen Psychiatry       Date:  2005-05
View more
  25 in total

1.  GWAS, cytomegalovirus infection, and schizophrenia.

Authors:  Jakob Grove; Anders D Børglum; Brad D Pearce
Journal:  Curr Behav Neurosci Rep       Date:  2014-12-01

Review 2.  Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

Authors:  Yavuz Ayhan; Ross McFarland; Mikhail V Pletnikov
Journal:  Prog Neurobiol       Date:  2015-10-25       Impact factor: 11.685

Review 3.  Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells.

Authors:  Kristen J Brennand; Melissa A Landek-Salgado; Akira Sawa
Journal:  Biol Psychiatry       Date:  2013-11-15       Impact factor: 13.382

Review 4.  Modeling Psychiatric Disorder Biology with Stem Cells.

Authors:  Debamitra Das; Kyra Feuer; Marah Wahbeh; Dimitrios Avramopoulos
Journal:  Curr Psychiatry Rep       Date:  2020-04-21       Impact factor: 5.285

5.  Increased BDNF expression in fetal brain in the valproic acid model of autism.

Authors:  Luis E F Almeida; Clinton D Roby; Bruce K Krueger
Journal:  Mol Cell Neurosci       Date:  2014-01-28       Impact factor: 4.314

6.  Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii.

Authors:  Geetha Kannan; Joshua A Crawford; ChunXia Yang; Kristin L Gressitt; Chinezimuzo Ihenatu; Irina N Krasnova; Jean Lud Cadet; Robert H Yolken; Emily G Severance; Mikhail V Pletnikov
Journal:  Neurobiol Dis       Date:  2016-03-08       Impact factor: 5.996

7.  One minute ultraviolet exposure inhibits Toxoplasma gondii tachyzoite replication and cyst conversion without diminishing host humoral-mediated immune response.

Authors:  Geetha Kannan; Emese Prandovszky; Curtis B Steinfeldt; Kristin L Gressitt; ChunXia Yang; Robert H Yolken; Emily G Severance; Lorraine Jones-Brando; Mikhail V Pletnikov
Journal:  Exp Parasitol       Date:  2014-08-14       Impact factor: 2.011

Review 8.  Clozapine as a Model for Antipsychotic Development.

Authors:  Frederick C Nucifora; Marina Mihaljevic; Brian J Lee; Akira Sawa
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 9.  Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.

Authors:  Frederick C Nucifora; Edgar Woznica; Brian J Lee; Nicola Cascella; Akira Sawa
Journal:  Neurobiol Dis       Date:  2018-08-29       Impact factor: 5.996

10.  Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 × DISC1.

Authors:  Colm M P O'Tuathaigh; Fabio Fumagalli; Lieve Desbonnet; Francesc Perez-Branguli; Gerard Moloney; Samim Loftus; Claire O'Leary; Emilie Petit; Rachel Cox; Orna Tighe; Gerard Clarke; Donna Lai; Richard P Harvey; John F Cryan; Kevin J Mitchell; Timothy G Dinan; Marco A Riva; John L Waddington
Journal:  Schizophr Bull       Date:  2016-09-09       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.